NCT03549416 BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis Status RECRUITING Phase N/A
NCT03546907 Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT03530267 Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer Status COMPLETED Phase PHASE2
NCT03529123 Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India) Status COMPLETED Phase PHASE3
NCT03521934 Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) Status TERMINATED Phase PHASE3
NCT03515629 REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer Status TERMINATED Phase PHASE3
NCT03514732 Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep Disorders Status COMPLETED Phase PHASE1
NCT03510884 An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT03510715 An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT03492489 Expanded Access Protocol for Cemiplimab in Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma Status NO_LONGER_AVAILABLE Phase N/A
NCT03485677 Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3 Status COMPLETED Phase PHASE3
NCT03463135 A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients Status COMPLETED Phase PHASE1
NCT03462069 Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension Status COMPLETED Phase PHASE2
NCT03462017 Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT03449758 Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT03439943 Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease Status COMPLETED Phase PHASE2
NCT03437720 Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver Disease Status WITHDRAWN Phase PHASE2